Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversibility of Olfactory Loss in Patients With Idiopathic Parkinson's Disease Following Treatment With Rasagiline

NCT00902941 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT00902941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00902941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversibility of Olfactory Loss in Patients With Idiopathic Parkinson's Disease Following Treatment With Rasagiline
Lead sponsor
Technische Universität Dresden
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2009
Completion date
February 29, 2012
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson´s disease